How many people does AstraZeneca employ worldwide?
We employ around 51,700 people:
- 46% in Europe;
- 28% in the Americas
- 26.5% in Asia-Pacific
How many shares does AstraZeneca have outstanding?
The total number of shares in issue at 31 March 2013 was 1,250 million.
On what stock exchange is AstraZeneca traded and what is the stock symbol?
AstraZeneca is traded on the London, New York and Stockholm Stock Exchanges. The symbol is AZN in all three markets.
What accounting convention does AstraZeneca adhere to?
AstraZeneca adheres to the International Financial Reporting Standards (IFRS) and International Accounting Standards (IAS) with appropriate conversion to US GAAP being shown in our financial statements.
What is AstraZeneca's current debt rating?
Long term: A2, Short term: P-1, Outlook: Stable
Standard & Poor's :
Long term AA-, Short term A-1+, Outlook: Negative
Long term AA-, Short term F1+, Outlook: Stable
What is AstraZeneca's CUSIP number for it's ADRs/ADs traded on the New York Stock Exchange?
What is AstraZeneca's offical accounting currency?
AstraZeneca reports in US dollars.
When is AstraZeneca's next earnings release?
AstraZeneca will announce second quarter and half year results on Thursday 1 August 2013.
When is the AstraZeneca annual meeting?
The date for the 2013 Annual General Meeting will be Thursday 25 April 2013.
When was AstraZeneca PLC formed?
AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of Sweden and Zeneca PLC of UK.
Where can I find historical financial information on AstraZeneca?
This information can be found in the financial results section.
When will I receive my next dividend payment?
For dividend information, please see this page:
Can AstraZeneca pay my dividends directly into my bank or building society account?
Yes it is possible to have your dividends paid directly into your bank or building society.
If you are a UK shareholder please complete the request for payment of dividend form and forward it to Equiniti (formerly Lloyds TSB Registrars).
If you are a US shareholder please go to the Investor Services section of the JP Morgan ADR website.
If you are a Swedish shareholder please contact your personal broker or if you hold a VPC account contact the VPC on +46 (0) 8 402 9000.
Does AstraZeneca have a dividend re-investment plan?
At present AstraZeneca does not have a dividend re-investment plan.
I am a non-taxpayer; can I have my AstraZeneca dividends paid gross?
No, it is not possible to have your dividends paid gross.
Where can I find dividend information?
Please visit our dividend section.
My personal details have changed - whom do I contact?
This will depend on where your shares are held:
If you are a UK shareholder either complete one of the online forms or alternatively call Equiniti (formerly Lloyds TSB Registrars) on 0800 389 1580.
If you are a Swedish shareholder please contact your broker or if you hold a VPC account call the VPC on 08 402 9000.
If you are a US shareholder please go to the JPMorgan Chase Bank website or alternatively call them on 888 697 8018.
Who do I contact to :- - request information on my account? - transfer stock? - request a share certificate replacement?
I am a UK shareholder. How do I allocate my cost basis of AstraZeneca shares to my Syngenta distribution?
I am a US shareholder. How do I allocate my cost basis of AstraZeneca shares to my Syngenta distribution?
I still hold Astra AB shares. What course of action should i take?
View a letter to Astra AB shareholders (PDF 5kb)
A legal representative, Peter Haglund, has been appointed to act on behalf of minority shareholders. He can be contacted at Advokatfirman Sodermark, Box 14055, SE 104 40 Stockholm, Sweden, telephone +46 8 670 57 50 and fax +46 8 663 67 20.
What was the opening price of AstraZeneca PLC shares?
What was the value of Zeneca shares when it demerged from ICI?
Shares in Zeneca Group PLC acquired on demerger from ICI will be treated as having a base cost for capital gains tax purposes ascertained by reference to the values of Zeneca and ICI shares on 1 June 1993 calculated in accordance with the provisions of Section 272 of the Taxation of Chargeable gains Act 1992. The base cost of any holding of ICI Shares on that date will be adjusted on the same basis.
The relevant prices on The London Stock Exchange on 1 June 1993 were:
Zeneca - 625.75p and ICI - 631.75p
The base cost of the pre-merger ICI Shares will therefore be split between the post-demerger Zeneca and ICI Shares in the proportion:
Zeneca -- 0.49761 and ICI -- 0.50239
When Astra AB and Zeneca PLC merged how were the shares split / merged?
Astra AB and Zeneca PLC shares were merged on 6th April 1999.
1 Astra share : 0.5045 AstraZeneca share
1 Zeneca share : 1 AstraZeneca share
When did AstraZeneca demerge its agrochemical business?
AstraZeneca demerged its agrochemical business on 13 November 2000.